TRDA Financials

Entrada Therapeutics Inc - Financial statements & key metrics

Stock Price

$7.21

Market Cap

$274.40M

P/E Ratio

12.5

EPS

$1.76

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$210.78M

Gross Profit

Operating Income

Net Income

$65.63M

EPS (Diluted)

$1.68

Balance Sheet Highlights

Total Assets

$526.32M

Total Liabilities

$97.64M

Shareholders Equity

Cash & Equivalents

$500,000

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-41.56M

CapEx

Free Cash Flow

Profitability Metrics

Net Margin

31.1%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is TRDA revenue?

TRDA's most recent quarterly revenue was $210.78M. Annual revenue can be calculated by summing the four most recent quarters.

Is TRDA profitable?

TRDA reported a profit of $65.63M in the most recent quarter. The net profit margin is 31.1%.

What is TRDA market cap?

TRDA has a market capitalization of $274.40M, making it a small-cap stock.

Does TRDA have debt?

View TRDA's balance sheet for debt information.

What is TRDA cash flow?

Cash flow data is available in the full financial statements.